HIV research cuts impact progress on work to end epidemic : NPR

PIEN HUANG, HOST:

Throughout his first time period, President Trump laid out a daring proposal throughout a State of the Union deal with.

(SOUNDBITE OF ARCHIVED RECORDING)

PRESIDENT DONALD TRUMP: My finances will ask Democrats and Republicans to make the wanted dedication to eradicate the HIV epidemic in the US inside 10 years. We’ve got made unimaginable strides, unimaginable.

(APPLAUSE)

HUANG: The Trump administration’s aim of eliminating HIV within the U.S. led to a swell of analysis and funding to check the virus. However within the opening months of his second time period, the Trump administration slashed hundreds of Public Well being jobs and gutted funding for scientific analysis, together with grants and funds for HIV and AIDS analysis. What does this imply for the way forward for HIV analysis within the U.S.? Dr. John Brooks is the previous chief medical officer to the CDC’s division of HIV prevention, and he joins me now. Dr. Brooks, welcome to ALL THINGS CONSIDERED.

JOHN BROOKS: Nicely, Pien, thanks. It is a pleasure to be right here, and I admire your consideration to this concern.

HUANG: So to begin with, are you able to give us a way of the place HIV analysis stood earlier than these cuts?

BROOKS: Nicely, you already know, HIV analysis has been in place because the discovery of the virus as the reason for superior HIV illness, which we used to name AIDS. And it is, you already know, made unimaginable strides. We are actually at a spot, on account of constant funding via principally federal help, that is found superb medication that may assist us each deal with HIV to maintain an individual wholesome but in addition to stop HIV.

HUANG: Have been there any remedies that we had been type of – you already know, you are speaking about remedies which were developed and are on the market working for individuals. Was there something additionally that was within the works that we have not fairly gotten to but?

BROOKS: Yeah, so a few essential issues. Initially, there was a decadeslong pursuit of an HIV vaccine, and that analysis, in addition to analysis for an HIV remedy, seems to have been canceled. That was principally analysis funded by the NIH. A vaccine can be unimaginable if we may have it – monumental public well being influence, gigantic financial advantages, in addition to the scientific developments it can present and has supplied prior to now. Ditto for an HIV remedy. Secondly, the best way that we may give individuals medication, each to deal with their an infection and to guard individuals from getting contaminated, are advancing very quickly. A brand new drug, lenacapavir, has just lately been authorised not just for treating but in addition for stopping HIV. And uniquely, it is easy to manage. It is about as simple to manage as a vaccine, and it might defend an individual for as much as six months.

HUANG: So decreasing or eliminating HIV requires a two-pronged strategy. There’s the prevention a part of it after which the therapy a part of it. And I am questioning the way you see these cuts impacting every of these approaches.

BROOKS: One of many issues that worries me is that the main focus of the present administration with regard to HIV – which by the way is included as a brand new a part of the Administration for a Wholesome America – that HIV bureau or division, no matter it is finally named, appears extremely targeted on simply therapy. However I believe these of us who work in infectious illnesses know nicely that therapy isn’t going to be the best way you are going to get out of any epidemic. Prevention is a crucial element. And what we’re seeing now could be notably round prevention analysis and prevention actions, an actual discount in what’s being carried out.

HUANG: So given the place we’re, and that, you already know, the truth that Trump’s initiative to eradicate HIV within the U.S. remains to be being funded, such as you stated, possibly below the brand new Administration for a Wholesome America, whilst different HIV analysis is being reduce, do you suppose the U.S. can nonetheless attain this aim of eliminating HIV by 2030?

BROOKS: Nicely, I am a born optimist, and I’m hopeful. However truthfully, I believe that with the cuts being made in analysis and, particularly, the outstanding and, for my part, draconian cuts being made to federal funding in HIV prevention, are going to result in a rise in new HIV infections nationally. We’ve got made nice strides on this nation below the president’s first-term signature initiative to eradicate the HIV epidemic in America. Within the first 4 years that it was in impact, we have seen a 12% decline in new infections nationally and a 19% decline in deaths on account of HIV.

HUANG: It feels like what you are saying, Dr. Brooks, is that present HIV sufferers will nonetheless have the ability to entry therapy, however you are notably nervous in regards to the prevention a part of it, the prevention of latest individuals from getting HIV. Is that proper?

BROOKS: That is completely proper. You recognize, PrEP, this treatment that’s given to stop an infection – it stands for pre-exposure prophylaxis – has made terrific advances. There is a new drug that is on the market that you just solely must take twice a yr via injection that may be administered as simply as a vaccine. Nevertheless, the drug could also be out there, and it might be very potent, however not all people has entry to it. To succeed in this drug and to get that safety, you’ll want to remember that you’re in danger for HIV and study that you do not have HIV, so the drug can defend you. And then you definitely want to have the ability to get to a spot that may administer it, you want to have the ability to afford it, and also you want to have the ability to keep engaged within the type of care that you’ll want to administer the drug so long as you want it.

HUANG: That is Dr. John Brooks, former chief medical officer to the CDC’s Division of HIV Prevention. Dr. Brooks, thanks for becoming a member of us.

BROOKS: Thanks very a lot. Take care.

Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional info.

Accuracy and availability of NPR transcripts could fluctuate. Transcript textual content could also be revised to appropriate errors or match updates to audio. Audio on npr.org could also be edited after its unique broadcast or publication. The authoritative file of NPR’s programming is the audio file.